CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

IMPACT BIOMEDICAL INC.

IBO
$55MMicro Cap

Next catalyst

Phase 2December 2026

IMP9064

Solid Tumor

Get an email about IBO's next catalysts

Track IMPACT BIOMEDICAL (IBO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (Phase 2 readout).See the timeline

Catalyst Timeline

2 upcoming, 2 past

Phase 2Next

IMP9064 Phase 2 Est. Readout

December 2026~IMP906461

Estimated primary completion for IMP9064 trial (NCT05269316) in Solid Tumor. Topline data typically follows completion by weeks to months.

Source
Phase 2

Senaparib Phase 2 Est. Readout

October 2027~Senaparib18

Estimated primary completion for Senaparib trial (NCT06617923) in Ovary Cancer. Topline data typically follows completion by weeks to months.

Source

How IBO's past catalysts played out

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaWEST HENRIETTA2 employees
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in IMPACT BIOMEDICAL INC.'s drug pipeline?β†’

CatalystAlert tracks 5 drug candidates in IMPACT BIOMEDICAL INC.'s (IBO) pipeline across Phase 3, Phase 2. Its lead program is IMP4927 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is IMPACT BIOMEDICAL INC.'s next FDA catalyst?β†’

IMPACT BIOMEDICAL INC.'s (IBO) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track IBO biotech catalysts?β†’

Add IBO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow IMPACT BIOMEDICAL INC.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply